Literature DB >> 28739029

IL-9 and Th9 cells in health and diseases-From tolerance to immunopathology.

Junhui Li1, Shuqiu Chen2, Xiang Xiao2, Yong Zhao3, Wenjun Ding4, Xian C Li5.   

Abstract

CD4+ T cells have the capacity to differentiate into various T helper (Th) cell subsets after activation, and by acquiring distinct cytokine profiles and effector functions, they regulate the nature as well as the outcomes of immune responses. Th9 cells are a relatively new member in the Th cell family. The signature cytokine for Th9 cells is IL-9, a cytokine in the IL-2Rγc-chain family. Over the past few years, there has been an explosion of knowledge on the roles of Th9 cells in immunity and immunopathology, but the exact mechanisms in the control of Th9 cells remain poorly defined. This apparent paradox presents both challenges and opportunities. Here we review recent advances in our understanding of the fundamental biology of IL-9 and Th9 cells, highlighting the challenges and unanswered questions in the field. We also discuss potential opportunities in targeting Th9 cells for therapeutic purposes in the clinic.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Immunity and immunopathology; Th9; Therapeutic purposes; Transcription mechanism

Mesh:

Substances:

Year:  2017        PMID: 28739029      PMCID: PMC5632571          DOI: 10.1016/j.cytogfr.2017.07.004

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  75 in total

Review 1.  Discovery and initial characterization of Th9 cells: the early years.

Authors:  Edgar Schmitt; Tobias Bopp
Journal:  Semin Immunopathol       Date:  2016-11-28       Impact factor: 9.623

Review 2.  Th9 cells in immunity and immunopathological diseases.

Authors:  Markus F Neurath; Mark H Kaplan
Journal:  Semin Immunopathol       Date:  2016-11-29       Impact factor: 9.623

3.  Mast cells are essential intermediaries in regulatory T-cell tolerance.

Authors:  Li-Fan Lu; Evan F Lind; David C Gondek; Kathy A Bennett; Michael W Gleeson; Karina Pino-Lagos; Zachary A Scott; Anthony J Coyle; Jennifer L Reed; Jacques Van Snick; Terry B Strom; Xin Xiao Zheng; Randolph J Noelle
Journal:  Nature       Date:  2006-08-20       Impact factor: 49.962

4.  Differential expression of T-cell growth factors in rejecting murine islet and human renal allografts: conspicuous absence of interleukin (IL)-9 despite expression of IL-2, IL-4, IL-7, and IL-15.

Authors:  X C Li; A D Schachter; M S Zand; Y Li; X X Zheng; W E Harmon; T B Strom
Journal:  Transplantation       Date:  1998-07-27       Impact factor: 4.939

5.  Gcn5 is required for PU.1-dependent IL-9 induction in Th9 cells.

Authors:  Ritobrata Goswami; Mark H Kaplan
Journal:  J Immunol       Date:  2012-08-17       Impact factor: 5.422

6.  IL-4-, TGF-β-, and IL-1-dependent expansion of parasite antigen-specific Th9 cells is associated with clinical pathology in human lymphatic filariasis.

Authors:  Rajamanickam Anuradha; Parakkal Jovvian George; Luke E Hanna; Vedachalam Chandrasekaran; Paul Kumaran; Thomas B Nutman; Subash Babu
Journal:  J Immunol       Date:  2013-08-02       Impact factor: 5.422

7.  Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells.

Authors:  Rahul Purwar; Christoph Schlapbach; Sheng Xiao; Hong Soon Kang; Wassim Elyaman; Xiaodong Jiang; Anton M Jetten; Samia J Khoury; Robert C Fuhlbrigge; Vijay K Kuchroo; Rachael A Clark; Thomas S Kupper
Journal:  Nat Med       Date:  2012-07-08       Impact factor: 53.440

8.  The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation.

Authors:  Hua-Chen Chang; Sarita Sehra; Ritobrata Goswami; Weiguo Yao; Qing Yu; Gretta L Stritesky; Rukhsana Jabeen; Carl McKinley; Ayele-Nati Ahyi; Ling Han; Evelyn T Nguyen; Michael J Robertson; Narayanan B Perumal; Robert S Tepper; Stephen L Nutt; Mark H Kaplan
Journal:  Nat Immunol       Date:  2010-05-02       Impact factor: 25.606

9.  IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells.

Authors:  Valérie Dardalhon; Amit Awasthi; Hyoung Kwon; George Galileos; Wenda Gao; Raymond A Sobel; Meike Mitsdoerffer; Terry B Strom; Wassim Elyaman; I-Cheng Ho; Samia Khoury; Mohamed Oukka; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2008-11-09       Impact factor: 25.606

10.  Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness.

Authors:  U A Temann; G P Geba; J A Rankin; R A Flavell
Journal:  J Exp Med       Date:  1998-10-05       Impact factor: 14.307

View more
  21 in total

1.  Cloning and functional testing of rhesus macaque (Macaca mulatta) IL-9 and IL-33.

Authors:  Sanghita Sarkar; Ann J Hessell; Nancy L Haigwood; James J Kobie
Journal:  J Med Primatol       Date:  2020-02-04       Impact factor: 0.667

2.  Glycogen synthase kinase-3 promotes T helper type 17 differentiation by promoting interleukin-9 production.

Authors:  Dongmei Han; Eva M Medina-Rodriguez; Jeffrey A Lowell; Eléonore Beurel
Journal:  Immunology       Date:  2020-05-08       Impact factor: 7.397

3.  Calcitriol Regulates the Differentiation of IL-9-Secreting Th9 Cells by Modulating the Transcription Factor PU.1.

Authors:  Shachi Pranjal Vyas; Arman Kunwar Hansda; Mark H Kaplan; Ritobrata Goswami
Journal:  J Immunol       Date:  2020-01-13       Impact factor: 5.422

4.  Control of CD4+ T Cell Differentiation and Function by PI3K Isoforms.

Authors:  Benjamin Cameron; Syed Aymaan Zaheer; Margarita Dominguez-Villar
Journal:  Curr Top Microbiol Immunol       Date:  2022       Impact factor: 4.737

5.  Effect of crosstalk between Th17 and Th9 cells on the activation of dermal vascular smooth muscle cells in systemic scleroderma and regulation of tanshinone IIA.

Authors:  Mengguo Liu
Journal:  An Bras Dermatol       Date:  2022-09-15       Impact factor: 2.113

Review 6.  Obesity, Inflammation, and Immune System in Osteoarthritis.

Authors:  Udhaya Nedunchezhiyan; Ibin Varughese; Antonia RuJia Sun; Xiaoxin Wu; Ross Crawford; Indira Prasadam
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

7.  XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis.

Authors:  Assaf Weiner; Ziv Ben-Ari; Mathias Heikenwälder; Eran Elinav; Ido Amit; Aleksandra Deczkowska; Eyal David; Pierluigi Ramadori; Dominik Pfister; Michal Safran; Baoguo Li; Amir Giladi; Diego Adhemar Jaitin; Oren Barboy; Merav Cohen; Ido Yofe; Chamutal Gur; Shir Shlomi-Loubaton; Sandrine Henri; Yousuf Suhail; Mengjie Qiu; Shing Kam; Hila Hermon; Eylon Lahat; Gil Ben Yakov; Oranit Cohen-Ezra; Yana Davidov; Mariya Likhter; David Goitein; Susanne Roth; Achim Weber; Bernard Malissen
Journal:  Nat Med       Date:  2021-05-20       Impact factor: 53.440

Review 8.  Innate immunity at the crossroads of healthy brain maturation and neurodevelopmental disorders.

Authors:  Kristine E Zengeler; John R Lukens
Journal:  Nat Rev Immunol       Date:  2021-01-21       Impact factor: 108.555

9.  IL-9 Deficiency Promotes Pulmonary Th17 Response in Murine Model of Pneumocystis Infection.

Authors:  Ting Li; Heng-Mo Rong; Chao Zhang; Kan Zhai; Zhao-Hui Tong
Journal:  Front Immunol       Date:  2018-05-25       Impact factor: 7.561

10.  Guidance of super-enhancers in regulation of IL-9 induction and airway inflammation.

Authors:  Xiang Xiao; Yihui Fan; Junhui Li; Xiaolong Zhang; Xiaohua Lou; Yaling Dou; Xiaomin Shi; Peixiang Lan; Yue Xiao; Laurie Minze; Xian Chang Li
Journal:  J Exp Med       Date:  2018-01-16       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.